The side effects are largely the same, such as nausea, vomiting, diarrhea, or stomach discomfort
Details of the CpG island size, location, and CpG content are described in the supplementary methods (Supplementary Table S3)
While BPC-157 has shown hepatoprotective properties in animal studies, you want confirmation not assumptions that your liver is fine
IF binds to Vitamin B12 and the complex is transported across the cell membrane bound to another glycoprotein called transcobalamin. But what happens if you, the patient, have insufficient amounts of IF to facilitate B12 absorption
Why It Was in Category 2 MOTs-C was placed in Category 2 along with the other peptides, reflecting the FDA's broader concerns about safety data sufficiency for peptide compounding
They will guide you through the process, address any concerns, and tailor the treatment to ensure your safety and optimal results